Why pharmacies are still struggling to obtain medicines

NHS patients are being forced into “rounds of phone calls and anxiety” to secure their prescriptions amid a worsening shortage of key pharmaceuticals, said the BBC.

Access to prescription medication in England is “at its most fragile point in years”, with people suffering from heart conditions, stroke risks, eye infections, bipolar disorder and ADHD among those reporting issues obtaining the medications they depend on.

‘Significant pressure’

Medicines UK, which represents drugmakers responsible for 85% of all NHS prescriptions, warned last month that it was “increasingly concerned” about the supply of certain active pharmaceutical ingredients, some of which are now in very short supply. This could place “significant pressure” on the NHS as early as June and increase costs for the health service when sourcing these medicines.

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

Sign up for The Week's Free Newsletters

Join more than 350,000 subscribers and keep yourself informed with a selection of The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.

Join more than 350,000 subscribers and keep yourself informed with a selection of The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.

Sign up

Drugs containing aspirin and paracetamol are among those at risk, as they are manufactured using by-products from the petrochemical industry, which has been affected by blockades in the Strait of Hormuz. In the UK, pharmacies are reportedly charging 20–30% more for over-the-counter medicines, said Al Jazeera.

Some pharmaceutical logistics routes rely on sea and air transport hubs in the Gulf, Frederic Schneider from the Middle East Council on Global Affairs, told the outlet. These routes are particularly fragile because many medicines require special handling, such as continuous cold storage, which has been disrupted by the war.

Richard Sullivan, professor of cancer and global health at King’s College London, told the British Medical Journal that there are already signs of “disruption in supply chains for cancer drugs”.

Complicated process

“Surging global prices” are contributing to the supply problems, and this is being exacerbated by the “complicated process of funding medicines”, said the BBC. The NHS reimburses pharmacies a fixed amount for each medicine they dispense, and pharmacies are expected to procure the drugs at or below that price.

When the cost of a medicine rises above the NHS reimbursement rate, it is added to the government’s price concessions list, which reached a record 210 medicines in April. Pharmacies are then reimbursed at the updated concession rate. However, when market prices rise rapidly – sometimes exceeding both the original tariff and the concession rate – pharmacies may be forced to supply medicines at a loss. This makes it more difficult to maintain stock levels and increases the risk of delays or unexpected shortages for patients.

The war in the Middle East has “aggravated the situation”, it is “not the sole reason for the shortage”, said Pharmacy Business. Around 60% of shortages are caused by manufacturing bottlenecks, alongside insufficient reserves of medicines and their raw materials.

A House of Lords report published in February called for improved leadership and strategy on medicine supply in the UK. Peers are urging long-term solutions to address the crisis, including sustained investment in domestic manufacturing, stronger political intervention, and making the issue a national priority. The country is currently “heavily dependent” on foreign manufacturing, particularly from companies based in India, Ireland, and Israel, said Pharmacy Business.

The government has said it is working to boost Britain’s domestic medicine manufacturing industry. A spokesperson told The Telegraph that this includes “offering financial incentives for the manufacturing of more medicines”.